obat anak kecil

34
oleh oleh oleh oleh Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. Mohd Mohd Mohd Mohd Aminuddin Aminuddin Aminuddin Aminuddin KK KK KK KK Manong Manong Manong Manong , PKD Kuala Kangsar , PKD Kuala Kangsar , PKD Kuala Kangsar , PKD Kuala Kangsar

Upload: amir-ihsan

Post on 10-Sep-2015

240 views

Category:

Documents


2 download

DESCRIPTION

Pediatric Medication Malaysia

TRANSCRIPT

  • oleholeholeholeh

    Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. Muhammad Amir Ihsan B. MohdMohdMohdMohd AminuddinAminuddinAminuddinAminuddin

    KK KK KK KK ManongManongManongManong , PKD Kuala Kangsar, PKD Kuala Kangsar, PKD Kuala Kangsar, PKD Kuala Kangsar

  • Co

    n

    t

    e

    n

    t

    s

    Introduction

    Pharmacokinetic of Children A, D, M, E

    Drug Therapy in Children Dose Calculation

    Appropriate Dosage form and route

    Counseling

    Summary

    References

    2

  • Introduction

    3

    Pediatric means..

    Day 1 1Month

    (Neonate)

    1- 11 years

    (Children)

    1 month 1year

    (Infants)

    Age:- 12-16

    years

    (Adolescents)

  • Importance of drug handling: Pediatric Pharmacology -Whats unique?

    Descriptive pharmacology (especially for new drugs) in pediatric patients is often lacking

    Animal studies not always predictive.

    Clinical studies in children fraught with ethical and financial hurdles.

    Administration of drug can also be problematic.

    Extremely small margin of error for the most fragile patients

    o Errors can be devastating

    o Individual variance unpredictable

    Highly Critical aspects in child treatment are

    Pharmacokinetic parameters

    Method of drug administration

    Dose & dosage forms

    4

  • The Normal Child:

    Growth and development are important indicators of a childs general well-being and pediatric practitioners should be aware of the normal development milestones in childhood.

    The World Health Organization (WHO) has published the widely used growth charts.

    Three important tools in developmental assessment.

    Height

    Weight

    Head circumference

    5

  • 6

  • Pharmacokinetics: There is high importance of clinical pharmacokinetics in optimization of drug therapy.

    Drugs that are safe and effective in one group of pediatric patients may be ineffective or toxic in another, so an understanding of variability in drug disposition is essential if children are to receive rational and appropriate drug therapy.

    7

    AD

    MEABSORBTION

    DISTRIBUTION

    METABOLISM

    EXCRETION

  • Absorption from GI tract

    Two factors affecting the absorption of drugs from the G.I. tract are pH-dependent passive diffusion and gastric emptying time.

    8

    PHPH Premature Infants- Elevated pH (More alkaline) higher serum concentrations of acid-labile drugssuch as penicillin and ampicillin

    Infant- Range from 6-8

    Gastric

    Emptying

    Gastric

    Emptying

    Infants/Neonate:- Prolonged gastricemptying time. Drug limited absorption inadults may be absorbed efficiently in apremature infant because of prolongedcontact time with GI mucosa.

    A

  • Absorption from Intramuscular route:-

    less predictable absorption in infant

    Factors: Less Muscle mass

    Poor perfusion in Muscle

    Insufficient muscular contractions

    Absorption from Skin :- Percutaneous absorption may be increased inneonate because of an underdeveloped epidermalbarrier (stratum corneum) and increased skinhydration.

    High ratio of total body surface area to totalbody weight increased exposure can producetoxic effects after topical use

    Eg: salicylic acid ointment and rubbing alcohol

    9

    A

  • 10

  • 11

    DTotal

    Body

    Water

    94% in the fetus, 85% in premature infants, 78% in full-term infants, and 60% in adults.

    Water soluble drugs has higher Vd (eg:Gentamicin)

    Plasma

    Protein

    Binding

    Neonates and infants have lower serum albumins and this may affect highly protein bound drugs

    The decrease in plasma protein binding of drugs can increase their apparent Vd

    (eg: phenytoin)

    Body

    Fat

    Amount of body fat is lower in neonates. Fat soluble drugs has lower Vd highly lipid-soluble drugs are distributed less widely in infants than in adults.

    (eg:Diazepam)

  • 12

  • Drug metabolism is substantially slower ininfants compared with older children andadults.

    Less maturation of various pathways ofmetabolism within a infant.

    E.g. :- sulfation pathway is well developed butthe glucuronidation pathway is undeveloped ininfants.

    The cause of the tragic chloramphenicol-induced Gray baby syndrome in newborninfants is a decreased metabolism ofchloramphenicol by glucuronyl transferases tothe inactive glucuronide metabolite.

    13

    M

  • Gray Baby Syndrome

    14

  • The processes of glomerular filtration, tubularsecretion, and tubular reabsorption determinethe efficiency of renal excretion. Theseprocesses may take several weeks to 1 yearafter birth to develop fully.

    Glomerular filtration rate is about 24 mL/minper 1.73 m2 in term infants.

    Glomerular filtration rate is 90-120 mL/min per1.73 m2 in adult.

    In infants, if possible then avoidChloramphenicol and Aminoglycoside(gentamicin,amikacin,and etc), because theirmetabolites are accumulated due to immaturefunction of kidney.

    15

    E

  • 16

    Drug therapy in pediatrics

    1. Dose calculation

    2. Choice of dosage form

    3. Adverse reaction

  • Six Rights of Pediatric Medication

    Administration

    RIGHT patient

    RIGHT medication

    RIGHT dose

    RIGHT route

    RIGHT time

    RIGHT documentation

    17

  • Pediatric Drug Therapy

    Color preference

    Pink Color

    Orange Color

    Yellow Color

    Taste preference

    Strawberry

    Orange

    Bubble gum

    Sweet

    18

  • 1. Dose calculation :- Height and Wt growth are rapidly changingfactors in childhood, which also influencesignificantly some pkinetic parameters. So, thisfactors should be considered during therapy. Sodose calculation is needed.

    Doses should be obtained from pediatric bookfor children.. For example, In india IAP-Drugformulary is reliable source for pediatricpractice and their important drugs.

    For many years, pediatric dosage calculationsused pediatric formulas such as Frieds rule,Youngs rule, and Clarks rule. These formulasare based on the weight of the child in pounds,or on the age of the child in months, and thenormal adult dose of a specific drug.

    19

  • 1) Youngs Rule :- (based on age)

    Pediatric dose =

    2) Frieds Rule :- (Age adjustment for infants)

    Infant Dose =

    3) Clarks Rule :- (based on body weight)

    Pediatric Dose =

    20

  • Other routes like.

    21

    2. Choice of Dosage form :-

    Rectal Route

    The rectal route absorption is probably

    similar to that of the upper part of GI tract.

    Useful for infant that unable to take orally.

    Parenteral Route:-

    Site of Access

    Safety from fluid overload

    Aware about Excipients

    Painfull

    Oral Route

    Tablets are less convenient

    Liquid preparation are easy to administer in

    accurate dose and to form in desirable dose

    by dilution

  • Mechanism is not cleared in adverse effect ofmany drugs in child. But it may be due toimmature pkinetic parameters and somemedication errors.

    Some well known adverse effect Tetracycline Teeth brown coloration

    Corticosteroids Growth suppression in Prepubertalchild.

    Paradoxical hyperactivity in child with phenobarbitaltreatment

    Aspirin treatment Reyes syndrom

    22

    4. Adverse reaction in therapy :-

  • 23

  • Su

    m

    m

    a

    r

    y

    Main key Points covered in topic..

    Children are not small adults

    Patient details such as age, weight and surfacearea need to be ensure appropriate dosing

    Weight and surface area may changesignificantly in a relatively short time period

    Pharmacokinetic changes in childhood areimportant and have a significant influence ondrug handling and need to considered whenchoosing an appropriate dosing regimen for achild

    The use of an unlicensed medicine in children isnot illegal although it must be ensured that thechoice of drug and dose is appropriate.

    24

  • 1) Parthasarthi G, Hausen KN and Nahata MC. Pediatricpharmacy practice. In parthasarthi G, Hausen KN andNahata MC edited A textbook of clinical pharmacypractice, 1st Edition. Universities Press Private Ltd,2008; 160-189.

    2) EMEA 2005 Reflection paper: formulations of choicefor the paediatric population. European MedicinesEvaluation Agency, London. Available online at:www.eniea.eu.int/pdfs/human/peg/19481005en.pdf

    3) International Committee on Harmonization 2000 Notefor guidance on clinical investigation of medicinalproducts in the paediatric population. European Agencyfor the Evaluation of Medicinal Products, London

    4) McIntyre J. Conroy S. Avery A et at 2000 Unlicensedand off label prescribing of drugs in general practice.Archives of Disease in Childhood 83: 498-501

    25

    R

    e

    f

    e

    r

    e

    n

    c

    e

    s

  • 5) National Institute for Clinical Excellence 2000 Guidanceon the use of inhaler systems (devices) in children underthe age of 5 years with chronic asthma. TechnologyAppraisal No 10. National Institute for ClinicalExcellence. London

    6) National Institute for Clinical Excellence 2002 Asthma-inhaler devices for older children. Technology AppraisalNo 38. National Institute for Clinical Excellence, London

    7) Scott E, Swanton J, McElnay Jet al 1995 Pharmacistsand child health. Centre for Pharmacy PostgraduateEducation/HMSO, London

    8) Turners. Longworth A, Nunn A J et al 1998 Unlicensedand off-label drug use in paediatric wards: prospectivestudy. British Medical Journal 316:343-345

    9) Yeung S C, Ensom M H 2000 Phenytoin and enteralfeedings: does evidence support an interaction? Annalsof Pharmacotherapy 3(7-8): 896-905

    26

  • 27

  • Benadryl Adult

    Diphenhydramine 14mg in 5ml

    Adult Dose 5ml-10ml QID

    Peads Dose 2.5ml -5ml QID

    28

    Benadryl Peads

    Diphenhydramine 7mg in 5ml

    2yr-6yr old dose 5ml-10ml QID

    6yr-12yr old 10ml-15ml QID

    Not recommended to child

    below 2years old

    VS

  • Anti-Emetic

    Promethazine 1mg/ml

    2yr 5yr old 5ml-15ml OD

    5yr-10yr old 10ml-25ml OD

    Not recommended to

    child below 2years old

    29

    Piriton

    Chlorpheniramine 2mg/5ml

    2yr 6yr old 2.5ml QID

    6yr 12yr old 5ml QID

    Not recommended to child

    below 2years old

  • GBH 0.1% lotion

    Anti Lice

    Neurotoxicity can cause

    seizure and death

    30

    EBB lotion 25%

    Anti scab and Anti lice

    Pediatric dilute to 12.5%

  • 31

    Steroid Cream

    Hydrocortisone 1%

    For More than 1yr old pt only

    Max 1 week treatment

    Betamethasone

    For more than 12yr old pt only

    Side Effect

    Pituitary and adrenal suppression

    Impair a child's growth

  • LMS oitment

    Contain Methyl Salicylate Oil 25%

    For pt more than 12yr old only

    Avoid in children Reye syndrome

    32

  • SAO 20%

    Keratolytic for warts and corn

    For pt more than 2yr old only

    33

  • SSD Cream 1%

    Antibiotic cream for application to burns

    wound.

    For pt more than 2yr old only

    34